Advanced Technologies for the Treatment of Diabetes
Contribution from continuous glucose monitors (CGMs) is a basic component of artificial pancreas (AP) frameworks, however, CGM execution issues keep on restricting advancement in AP research. While G4 PLATINUM has been incorporated into AP frameworks around the globe and used in numerous successful AP controller possibility studies, this system was intended to address the needs of overall CGM users as an adjunctive use system. This session explicitly addresses the heightened performance requirements for future AP studies.
- Track 1-1 New Therapeutic Mechanisms for Diabetes
- Track 2-2 New Discovery and Treatment for Type 2 Diabetes
- Track 3-3 Exploring novel therapies in diabetes treatment
- Track 4-4 Integrative gaming
- Track 5-5 CGM